Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds

Liwei Lang, Hanfei Ding, Xiaoguang Chen, Shi Yong Sun, Gang Liu, Chunhong Yan

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Summary Although transgene-based reporter gene assays have been used to discover small molecules targeting expression of cancer-driving genes, the success is limited due to the fact that reporter gene expression regulated by incomplete cis-acting elements and foreign epigenetic environments does not faithfully reproduce chemical responses of endogenous genes. Here, we present an internal ribosome entry site-based strategy for bicistronically co-expressing reporter genes with an endogenous gene in the native gene locus, yielding an in situ reporter assay closely mimicking endogenous gene expression without disintegrating its function. This strategy combines the CRISPR-Cas9-mediated genome-editing tool with the recombinase-mediated cassette-exchange technology, and allows for rapid development of orthogonal assays for excluding false hits generated from primary screens. We validated this strategy by developing a screening platform for identifying compounds targeting oncogenic eIF4E, and demonstrated that the novel reporter assays are powerful in searching for transcription-targeted lead compounds with high confidence.

Original languageEnglish (US)
Article number3080
Pages (from-to)957-964
Number of pages8
JournalChemistry and Biology
Volume22
Issue number7
DOIs
StatePublished - Jul 24 2015

Fingerprint

Lead compounds
Transcription
Reporter Genes
Assays
Genes
Clustered Regularly Interspaced Short Palindromic Repeats
Gene Expression
Recombinases
Neoplasm Genes
Transgenes
Epigenomics
Gene expression
Technology
Internal Ribosome Entry Sites
Lead
Screening
Molecules

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds. / Lang, Liwei; Ding, Hanfei; Chen, Xiaoguang; Sun, Shi Yong; Liu, Gang; Yan, Chunhong.

In: Chemistry and Biology, Vol. 22, No. 7, 3080, 24.07.2015, p. 957-964.

Research output: Contribution to journalArticle

@article{0a587c1bad0a47e4b2d85d0f375bd071,
title = "Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds",
abstract = "Summary Although transgene-based reporter gene assays have been used to discover small molecules targeting expression of cancer-driving genes, the success is limited due to the fact that reporter gene expression regulated by incomplete cis-acting elements and foreign epigenetic environments does not faithfully reproduce chemical responses of endogenous genes. Here, we present an internal ribosome entry site-based strategy for bicistronically co-expressing reporter genes with an endogenous gene in the native gene locus, yielding an in situ reporter assay closely mimicking endogenous gene expression without disintegrating its function. This strategy combines the CRISPR-Cas9-mediated genome-editing tool with the recombinase-mediated cassette-exchange technology, and allows for rapid development of orthogonal assays for excluding false hits generated from primary screens. We validated this strategy by developing a screening platform for identifying compounds targeting oncogenic eIF4E, and demonstrated that the novel reporter assays are powerful in searching for transcription-targeted lead compounds with high confidence.",
author = "Liwei Lang and Hanfei Ding and Xiaoguang Chen and Sun, {Shi Yong} and Gang Liu and Chunhong Yan",
year = "2015",
month = "7",
day = "24",
doi = "10.1016/j.chembiol.2015.06.009",
language = "English (US)",
volume = "22",
pages = "957--964",
journal = "Cell Chemical Biology",
issn = "2451-9448",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds

AU - Lang, Liwei

AU - Ding, Hanfei

AU - Chen, Xiaoguang

AU - Sun, Shi Yong

AU - Liu, Gang

AU - Yan, Chunhong

PY - 2015/7/24

Y1 - 2015/7/24

N2 - Summary Although transgene-based reporter gene assays have been used to discover small molecules targeting expression of cancer-driving genes, the success is limited due to the fact that reporter gene expression regulated by incomplete cis-acting elements and foreign epigenetic environments does not faithfully reproduce chemical responses of endogenous genes. Here, we present an internal ribosome entry site-based strategy for bicistronically co-expressing reporter genes with an endogenous gene in the native gene locus, yielding an in situ reporter assay closely mimicking endogenous gene expression without disintegrating its function. This strategy combines the CRISPR-Cas9-mediated genome-editing tool with the recombinase-mediated cassette-exchange technology, and allows for rapid development of orthogonal assays for excluding false hits generated from primary screens. We validated this strategy by developing a screening platform for identifying compounds targeting oncogenic eIF4E, and demonstrated that the novel reporter assays are powerful in searching for transcription-targeted lead compounds with high confidence.

AB - Summary Although transgene-based reporter gene assays have been used to discover small molecules targeting expression of cancer-driving genes, the success is limited due to the fact that reporter gene expression regulated by incomplete cis-acting elements and foreign epigenetic environments does not faithfully reproduce chemical responses of endogenous genes. Here, we present an internal ribosome entry site-based strategy for bicistronically co-expressing reporter genes with an endogenous gene in the native gene locus, yielding an in situ reporter assay closely mimicking endogenous gene expression without disintegrating its function. This strategy combines the CRISPR-Cas9-mediated genome-editing tool with the recombinase-mediated cassette-exchange technology, and allows for rapid development of orthogonal assays for excluding false hits generated from primary screens. We validated this strategy by developing a screening platform for identifying compounds targeting oncogenic eIF4E, and demonstrated that the novel reporter assays are powerful in searching for transcription-targeted lead compounds with high confidence.

UR - http://www.scopus.com/inward/record.url?scp=84937726616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937726616&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2015.06.009

DO - 10.1016/j.chembiol.2015.06.009

M3 - Article

C2 - 26144883

AN - SCOPUS:84937726616

VL - 22

SP - 957

EP - 964

JO - Cell Chemical Biology

JF - Cell Chemical Biology

SN - 2451-9448

IS - 7

M1 - 3080

ER -